Ideaya Biosciences (IDYA) Stock
Ideaya Biosciences (IDYA) closed at $31.83 on Nov 13, 2026; its Tenet Score is 62 of 100 against 409 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $31.83
- Nov 13, 2026
- Market cap
- $3.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 26.81 – 42.68
- low → high
- Tenet Score
- 62/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Ideaya Biosciences Inc scores 62/100. Solid. Strongest on financial health and value versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidate…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Indivior Pharmaceuticals Inc.INDV | 51 | $3.5B |
| Supernus Inc.SUPN | 47 | $3.5B |
| Acadia Pharmaceuticals IncACAD | 64 | $3.2B |
| Dyne Therapeutics IncDYN | 52 | $3.2B |
| Bausch Health Companies IncBHC | 50 | $3.1B |
| Xeris Biopharma Holdings IncXERS | 44 | $3.0B |
| Adma Biologics IncADMA | 67 | $3.0B |
| Denali Therapeutics IncDNLI | 53 | $3.0B |
| Vericel CorpVCEL | 59 | $2.9B |
| Xencor IncXNCR | 41 | $2.8B |
Common questions
What sector and industry is Ideaya Biosciences in?
Ideaya Biosciences is in the Healthcare sector and the Drugs industry.
What is Ideaya Biosciences' Tenet Score?
Ideaya Biosciences' Tenet Score is 62 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




